Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Raymond O. McCubrey"'
Autor:
Viet T. Le, Stacey Knight, Jeramie D. Watrous, Mahan Najhawan, Khoi Dao, Raymond O. McCubrey, Tami L. Bair, Benjamin D. Horne, Heidi T. May, Joseph B. Muhlestein, John R. Nelson, John F. Carlquist, Kirk U. Knowlton, Mohit Jain, Jeffrey L. Anderson
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
IntroductionLong-chain omega-3 polyunsaturated fatty acids (OM3 PUFA) are commonly used for cardiovascular disease prevention. High-dose eicosapentaenoic acid (EPA) is reported to reduce major adverse cardiovascular events (MACE); however, a combined
Externí odkaz:
https://doaj.org/article/a44e80d84b8a40ba8d46716230f9431b
Autor:
Raymond O. McCubrey, Steve M. Mason, Viet T. Le, Daniel L. Bride, Benjamin D. Horne, Kent G. Meredith, Nishant K. Sekaran, Jeffrey L. Anderson, Kirk U. Knowlton, David B. Min, Stacey Knight
Publikováno v:
Journal of Nuclear Cardiology. 30:46-58
Background With the increase in cardiac PET/CT availability and utilization, the development of a PET/CT-based major adverse cardiovascular events, including death, myocardial infarction (MI), and revascularization (MACE-Revasc) risk assessment score
Autor:
Christopher D. Willey, Eddy S. Yang, G. Yancey Gillespie, James A. Bonner, Tamara M. Burleson, Sherard Chiu, Raymond O. McCubrey, Timothy D. Rohrbach, Alexander C. Whitley, Patricia H. Hicks, Somaira Nowsheen, Tapan Mehta, Christine W. Duarte, Joshua C. Anderson, John S. Jarboe
PDF file, 148KB, Supplemental Figure S2 shows U251 knockdown supplemental data.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3380dc4cc07b8a095b5f9436659f725e
https://doi.org/10.1158/1078-0432.22443116
https://doi.org/10.1158/1078-0432.22443116
Autor:
Christopher D. Willey, Eddy S. Yang, G. Yancey Gillespie, James A. Bonner, Tamara M. Burleson, Sherard Chiu, Raymond O. McCubrey, Timothy D. Rohrbach, Alexander C. Whitley, Patricia H. Hicks, Somaira Nowsheen, Tapan Mehta, Christine W. Duarte, Joshua C. Anderson, John S. Jarboe
PDF file, 125KB.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66a8a60bdea27bbdffbbb5c79e9ab700
https://doi.org/10.1158/1078-0432.22443107
https://doi.org/10.1158/1078-0432.22443107
Autor:
Christopher D. Willey, Eddy S. Yang, G. Yancey Gillespie, James A. Bonner, Tamara M. Burleson, Sherard Chiu, Raymond O. McCubrey, Timothy D. Rohrbach, Alexander C. Whitley, Patricia H. Hicks, Somaira Nowsheen, Tapan Mehta, Christine W. Duarte, Joshua C. Anderson, John S. Jarboe
PDF file, 24KB, Supplemental Figure S1 shows GBM cell line proliferation data.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f066fa1cc6467305279638ef86b41aee
https://doi.org/10.1158/1078-0432.22443119
https://doi.org/10.1158/1078-0432.22443119
Autor:
Christopher D. Willey, Eddy S. Yang, G. Yancey Gillespie, James A. Bonner, Tamara M. Burleson, Sherard Chiu, Raymond O. McCubrey, Timothy D. Rohrbach, Alexander C. Whitley, Patricia H. Hicks, Somaira Nowsheen, Tapan Mehta, Christine W. Duarte, Joshua C. Anderson, John S. Jarboe
PDF file, 88KB, Supplemental Figure S3 shows U251 knockdown supplemental data including DNA repair and cell cycle.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::091f6b26581c6db1e922f9df6c23960c
https://doi.org/10.1158/1078-0432.22443113.v1
https://doi.org/10.1158/1078-0432.22443113.v1
Autor:
Christopher D. Willey, Eddy S. Yang, G. Yancey Gillespie, James A. Bonner, Tamara M. Burleson, Sherard Chiu, Raymond O. McCubrey, Timothy D. Rohrbach, Alexander C. Whitley, Patricia H. Hicks, Somaira Nowsheen, Tapan Mehta, Christine W. Duarte, Joshua C. Anderson, John S. Jarboe
Purpose: This study assessed whether myristoylated alanine-rich C-kinase substrate (MARCKS) can regulate glioblastoma multiforme (GBM) growth, radiation sensitivity, and clinical outcome.Experimental Design: MARCKS protein levels were analyzed in fiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d789377174d5b359acb15ba102dd86a2
https://doi.org/10.1158/1078-0432.c.6519683.v1
https://doi.org/10.1158/1078-0432.c.6519683.v1
Autor:
Christopher D. Willey, Eddy S. Yang, G. Yancey Gillespie, James A. Bonner, Tamara M. Burleson, Sherard Chiu, Raymond O. McCubrey, Timothy D. Rohrbach, Alexander C. Whitley, Patricia H. Hicks, Somaira Nowsheen, Tapan Mehta, Christine W. Duarte, Joshua C. Anderson, John S. Jarboe
PDF file, 102KB, Supplemental Figure S4 shows DAPI stained U251 control and knockdown cells after radiation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01373950c865276b522ee9a6882b2b19
https://doi.org/10.1158/1078-0432.22443110
https://doi.org/10.1158/1078-0432.22443110
Autor:
T J Bunch, David B. Min, Heidi T May, Raymond O McCubrey, Stacey Knight, Michael J. Cutler, Jeffrey L. Anderson, Kirk U. Knowlton, Steve Mason, Joseph B. Muhlestein, Viet T Le
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics. 26:648-655
Background: Flecainide is a useful antiarrhythmic for atrial fibrillation (AF). However, because of ventricular proarrhythmia risk, a history of myocardial infarction (MI) or coronary artery disease (CAD) is a flecainide exclusion, and stress testing
Autor:
Scott C. Woller, Scott M. Stevens, Tami L Bair, Heidi T May, Joseph B. Muhlestein, Jeffrey L. Anderson, T. Jared Bunch, Raymond O McCubrey, Stacey Knight
Publikováno v:
Circulation. 142
Objective: Both time in therapeutic range (TTR) for anticoagulation and depression are associated with dementia risk. However, it is unknown if depression impacts TTR or their combined effect on dementia risk. Methods: We studied 14,953 patients who